Ephs and ephrins are cell surface receptors that bind to each other and initiate distinct, bidirectional signalling pathways in processes known as forward (Eph) and reverse (ephrin) signalling. Previous work had shown that the loss of ephrinB1 protein alone or compound loss of EphB2 and EphB3 leads to cleft palate. Because of the bidirectional signalling capability of these molecules, it was not clear whether forward or reverse signalling caused the cleft palate in the ephrinB1 protein null or EphB2 and EphB3 compound null mice. We demonstrate that forward signalling is essential for palatogenesis. Foetuses with a cytoplasmically truncated EphB2 protein, which could initiate reverse but not forward signalling, and were protein null for EphB3 had a cleft palate. This happened because their palatal shelves, which could elevate in vivo and adhere and fuse in culture, were too small to contact one another. Small shelf size was due to reduced proliferation in the palatal mesenchyme.
Introduction
Development of the mammalian palate is a complex multi-step process. The anterior primary palate develops from the frontonasal processes and the posterior secondary palate from the maxillary processes. Defective development of the primary palate can lead to cleft lip and palate and defective development of the secondary palate to cleft palate. Cleft lip and palate are the most common human craniofacial disorders occurring at a frequency of approximately 1 in 700 births (Slavkin, 1992) . Mouse models of cleft palate have been used to gain a greater understanding of the mechanisms of palate development (for example: Rice et al., 2004; Ito et al., 2003; Zhang et al., 2002; Halford et al., 2000; Taya et al., 1999) . In this paper we are primarily concerned with the role of signalling by Ephs and ephrins in development of the mouse secondary palate.
The murine palate develops between embryonic day 8.5 (E8.5) and E15.5. Cranial neural crest (CNC) cells migrate into branchial arch 1 (BA1) and associate with craniopharyngeal ectoderm to form the maxillary processes (Ferguson, 1988) . The maxillary processes comprise a layer of undifferentiated epithelium that encloses loosely packed mesenchymal cells, embedded in a collagen type I-and III-rich extracellular matrix (ECM) (Silver et al., 1981) . At E11.5 the palatal mesenchyme cells are already specified within the maxillary processes. The shelves of the secondary palate begin extending vertically downwards from the maxillary processes on either side of the tongue. tate to a horizontal position above the tongue. Growth continues and at E14.5 the central third of the shelves (anterior-posterior) adhere to one another by their MEE, forming the medial edge seam (MES). Adhesion proceeds both anteriorly and posteriorly, generating a MES throughout the palate. The MES rapidly degenerates and establishes continuity of the mesenchyme by E15.5 throughout the now intact secondary palate (Ferguson, 1988) .
Ephs and ephrins are a family of cell surface receptors with important roles in regulating many aspects of embryonic development, including the palate, hindbrain, somites, skeleton, blood vessels and urinogenital system, as well as guidance of the migration of CNC cells and axons (Dravis et al., 2004; Compagni et al., 2003; Adams et al., 2001 Adams et al., , 1999 Birgbauer et al., 2000; Krull et al., 1997; Wang and Anderson, 1997; Orioli et al., 1996) . They are divided into two subclasses, A and B, according to their sequence homology and binding specificity. Because they exhibit mutual binding, Ephs and ephrins are often described as Eph 'receptors' and ephrin 'ligands'. However, each is capable of acting as both a ligand and receptor for the other. Eph-B and ephrinB proteins can be tyrosine phosphorylated in the cytoplasmic domain to generate a signal while ephrinA proteins have glycosylphosphotidylinositol membrane anchors (Kullander and Klein, 2002; Bruckner et al., 1997; Holland et al., 1996; Davis et al., 1994) . A convention has been established to differentiate between Eph and ephrin signalling; ''forward signalling'' refers to Eph signalling when bound by an ephrin and ''reverse signalling'' refers to ephrin signalling when bound by an Eph (Murai and Pasquale, 2003) .
Involvement of Ephs and ephrins in palate development is seen in the human disease craniofrontonasal syndrome where mutations in the ephrinB1 gene give rise to a range of cranial defects including cleft lip and palate (Wieland et al., 2004; Twigg et al., 2004; Torii et al., 2007) , whilst mutations in mice result in craniofacial and other skeletal defects, including cleft palate (Davy et al., 2004; Compagni et al., 2003) . Interestingly, ephrinB1 appears to have a dual role in palate development, firstly, through initiating forward signalling during palatal shelf formation and secondly, a requirement for ephrinB1 mediated reverse signalling in NC derived cells during palatal shelf elevation (Davy et al., 2004) . Double knock out of EphB2 and EphB3 in mice causes cleft palate, although neither single knock out is affected . This knock out experiment does not distinguish between requirements for forward and reverse signalling because Eph signalling is lost due to absence of the proteins and ephrin signalling is lost because of absence of activating ligands. In order to determine whether forward signalling is required for palate development, we studied mice that are EphB3 null and transgenic for a compound mutation of EphB2 , where the deleted cytoplasmic domain was replaced with b-galactosidase . The EphB2 protein cannot participate in forward signalling because its tyrosine kinase domain is missing but can activate reverse signalling because its extracellular domain acts as an ephrin ligand (Holland et al., 1997; Henkemeyer et al., 1996) . Therefore, any phenotypic effects present in EphB2 lacZ/lacZ
/EphB3
À/À foetuses but not in EphB3 À/À foetuses must be due to a loss of forward signalling. 
Results

EphB2 and EphB3 proteins are expressed throughout normal palate development
To determine the correlation between EphB2 and EphB3 expression and different stages of normal palate development, the temporal distribution of these proteins was analysed by immunohistochemistry of wild type foetuses. Expression of both EphB2 and EphB3 proteins was present during vertical palatal shelf growth (Fig. 1) . At E12.5 expression was weak in the palatal mesenchyme, particularly at the tip of the shelf (Fig. 1A and E) , relative to the maxilla ( Fig. 1A and E) . At E13.5, expression of both molecules was present throughout the palatal mesenchyme, (Fig. 1B and F) with weaker expression in the palatal epithelium. Intense expression was present in fusing shelves at E14.5 in the palatal mesenchyme ( Fig. 1C and G) and on the MES ( Fig. 1D and H). Thus, EphB2 and EphB3 were expressed at all stages of palate development, most strongly during horizontal growth. An expression analysis of ephrinB1/B2/B3 revealed mRNA expression throughout the E14.5 palate ( Supplementary  Fig. 1 ). Thus, both EphB2 and EphB3, in addition to a number of their ephrin ligands, are present in the palate during its development.
2.2.
A . No palatal clefting was observed in EphB3 À/À (n = 121) or wild-type CD1 foetuses (n = 51). The clefting frequency remained constant among EphB2 lacZ/lacZ / EphB3 À/À foetuses harvested from E15.5 through E19.5, demonstrating a failure of normal palate development rather than a fusion delay. Cleft palate was also observed in a single EphB2 +/lacZ /EphB3 À/À foetus (n = 1/73). As proportion of
EphB2
À/À /EphB3 À/À embryos died before E11.5 due to vascular defects Adams et al., 1999) , Mendelian ratios were analysed from E8.5 through E19.5. This revealed no pre-natal lethality in EphB2 (Fig. 2) . E12.5 palatal shelves of both genotypes were morphologically similar, extending vertically downwards from the maxillary processes on either side of the tongue ( Fig 
/EphB3
À/À shelves had elevated but failed to make contact ( Fig. 2E and F). At E15.5 the MES had completely broken down in all EphB3 À/À palates resulting in mesenchymal continuity ( Fig. 2G ) while some (n = 5/11) EphB2 lacZ/lacZ /EphB3 À/À palates opposed one another horizontally but had failed to make contact. Since all EphB2 lacZ/lacZ /EphB3 À/À shelves elevated normally it was concluded that clefting was not caused indirectly by another craniofacial abnormality. Moreover, since the shelves adhered to each other in culture (see below) and since some adhered and developed normally in vivo failure of adhesion between the MEE does not seem a likely cause of clefting. A more likely possibility seems to be that some of the elevated palatal shelves are simply too small to make midline contact.
EphB2
lacZ/lacZ /EphB3 -/-palatal shelves can adhere and fuse normally
Since EphB2 and EphB3 are present in MEE they may play a role in palatal shelf adhesion and fusion. To determine whether EphB2 lacZ/lacZ /EphB3 À/À palatal shelves were capable of adhering and fusing, isolated shelves were placed in contact in culture. Isolated EphB3 À/À shelves were used as controls. Shelves isolated from E14.5 foetuses prior to contact were used for short-term (2 and 4 h) cultures and immediately dehydrated to determine whether they adhered to one another. Dehydration caused those palatal shelves that had failed to adhere to shrink away from one another. There was no difference in the adhesive capability of EphB2
À/À and EphB3 À/À shelves ( Table 1) .
Pairs of E13.5 and E14.5 palatal shelves were placed in contact and cultured for 72 h to ascertain whether EphB2
À/À shelves were capable of normal MES formation and subsequent breakdown. Again, EphB3 À/À shelves were used as controls. MES formation and breakdown occurred normally in all cases. EphB3 À/À at E13.5 n = 8, at E14.5 n = 3,
lacZ/lacZ /EphB3 À/À at E13.5 n = 7, at E14.5 n = 4 (Fig. 3 ). In addition, one of two pairs of unfused shelves cultured from E16.5 EphB2 In order to determine whether small shelf size might contribute to cleft palate, cross-sectional area of the shelves was measured (Fig 4) . EphB2 lacZ/lacZ /EphB3 À/À shelves were 6% (E12.5), 10% (E13.5) and 18% (E14.5) smaller on average than EphB3 À/À shelves but the differences were not statistically significant at any age (Fig. 4A) . Scatter graphs were plotted to determine if there was a trend towards reduced shelf size in some of these foetuses. At E12.5 there appeared to be little difference in shelf size between EphB3 À/À and EphB2
À/À foetuses (Fig. 4B) . At E13.5 there was a slight trend towards reduced palatal shelf area in EphB2
and EphB3 is present in the palatal mesenchyme during vertical development at E12.5 and E13.5 (A, B, E and F). At E12.5, expression of both EphB2 and EphB3 is relatively weaker in the palatal shelf, particularly the tip, than in the maxilla (A, E). At E13.5, expression of both proteins is present throughout the palatal mesenchyme. Expression is also present in the palatal epithelium, though more weakly than in the mesenchyme. Expression is intense in the palatal mesenchyme during horizontal development at E14.5 (C and G). Enlargements from C and G show that both proteins are also expressed in the MES at E14.5 (D and H). Inset in A, B and C: negative controls were without primary antibody. T, tongue; ps, palatal shelf; M, maxillary process. Scale bars (A-C and E-G) = 100 lm, (D, H) = 20 lm.
foetuses (Fig. 4C) . At E14.5, in unfused palatal shelves, this trend was more apparent. Apart from a single EphB3 À/À control outlier (Fig. 4D, arrow) , there was a stronger trend towards reduced shelf area of EphB2 lacZ/lacZ /EphB3 À/À foetuses at E14.5, with 5 out of 8 foetuses having smaller shelf size than the EphB3 À/À controls (Fig. 4D) . Thus, a proportion of embryos had palatal shelves smaller than controls and this proportion is consistent with the low penetrance of cleft palate.
lacZ/lacZ /EphB3 À/À palatal shelves show decreased cell proliferation but no increase in apoptosis foetuses was quantified by BrdU labelling. No statistical differences in proliferation were found at any of the three ages measured (p > 0.05, MannWhitney U-test; Fig. 5A ). Plotted on a scatter graph, the proliferation rates of EphB3 À/À and EphB2 lacZ/lacZ /EphB3 À/À foetuses appeared comparable at E12.5 (Fig. 5B ) and E13.5 (Fig. 5C) . However, at E14.5 a proportion of the EphB2 
/EphB3
À/À foetuses was due to a failure of normal blood vessel development in the palate, immunohistochemistry for the vascular endothelial marker CD31 was performed (Fig. 6 ). CD31 staining was present in both EphB3 À/À and EphB2 lacZ/lacZ /EphB3 À/À palatal shelves (n = 4; ages E13.5 and E14.5). There were no reductions in staining in EphB2 lacZ/lacZ /EphB3 À/À foetuses, including all of those with No difference in their ability to adhere to one another was found at after either 2 or 4 h in culture. lower BrdU measurements, indicating that reduced proliferation was not caused by impaired blood supply. The TUNEL assay was used to determine whether there was increased apoptosis in palatal shelves EphB2 lacZ/lacZ / EphB3 À/À foetuses using EphB3 À/À mice as controls. Very few apoptotic cells were present in the palatal mesenchyme or epithelia, of foetuses from E12.5 to E14.5 in either genotype (n = 3 for controls and n = 6 for EphB2
), other than the MES at of fused shelves at E14.5 ( Supplementary  Fig. 2 Fig. 3A-F) . Cell density in E12.5-E14.5 palatal shelves was also found to be comparable in EphB3 À/À and EphB2
À/À foetuses, including those that were found to be smaller ( Supplementary Fig. 3G ) Thus, the smaller palatal shelves of EphB2 lacZ/lacZ /EphB3 À/À foetuses were not due to abnormal GAG deposition.
Discussion
These results demonstrate for the first time that Eph receptor forward signalling is involved in normal palate development. This conclusion is based on evidence showing that the EphB2-b-Gal fusion protein, which cannot initiate forward signalling because it lacks its kinase domain, remains capable of initiating reverse signalling by acting as a ligand for its cognate ephrin(s). Thus, Holland et al. (1997) showed that recombinant extracellular domain of EphB2 added to ephrin-expressing cells in culture caused tyrosine phosphorylation of the ephrin (see also Bruckner et al., 1997) Other in vivo studies with EphB2-b-Gal have suggested a ligand-like role in commissural axon guidance (Mendes et al., 2006; Orioli et al., 1996; Henkemeyer et al., 1996) . We suggest that a combination of EphB3 protein and EphB2 forward signalling is important for palate development.
We believe that the most likely explanation for palatal clefting in EphB2 lacz/lacz
/EphB3
À/À mice is that some of the palatal shelves are too small to make contact in the mid line. This leads to failure of adhesion between the MEE and of subsequent fusion. Our results show that mutant palatal shelves may account for the frequency of cleft palate (44%) in the mutants; only the smallest mutant shelves fail to adhere while the larger ones adhered and fused normally. Reduced EphB2 lacz/lacz /EphB3 À/À shelf size appears to be due to reduced mesenchymal cell proliferation at E14.5, the proportion of foetuses showing reduced proliferation (37.5%) also being comparable to the frequency of cleft palate. It is notable that the timing of reduced proliferation (maximum reduction at E14.5) also corresponds to the time of greatest EphB2 and EphB3 protein expression in palatal shelves. EphB2 has been shown to regulate cell proliferation both positively and negatively on a number of previous occasions. Positive roles for EphB2 include the regulation of vascular endothelial cell proliferation in a ligand dependent manner (Woods et al., 2002 ) and a co-operative role with EphB1 in regulating proliferation of neural progenitor cells (Chumley et al., 2007) . Interestingly, EphB2 and EphB3 are required for normal cell proliferation in the intestine and colon of the adult mouse with loss of EphB2 phosphorylation accompanied by reduced cell proliferation (Holmberg et al., 2006) .
How could Eph receptor forward signalling regulate cell proliferation in the palate? Although no downstream targets for an EphB2 mediated positive regulation of cell proliferation have been identified, some targets for other EphB receptors are known. EphB4 positively regulates cell proliferation, stimulating a pathway involving Akt, PI3K, nitric oxide synthase, ERK1/2 and protein kinase G (Steinle et al., 2003) . Another potential signalling cascade involves association of Eph receptors with Ryk, an orphan receptor tyrosine kinase essential for normal palate development (Halford et al., 2000) . Ryk has similar expression patterns to EphB2/B3 and its phosphorylation is dependent upon Eph receptor activation (Halford et al., 2000) . Stimulation of Ryk in EphB3 expressing NIH 3T3 cells (Halford and Stacker, 2001 ) caused a MAPK cascade and activation of p90-Rsk3, a substrate of ERK (Frodin and Gammeltoft, 1999) , to levels comparable to those obtained by growth factor stimulation (Katso et al., 1999) . We speculate that the cell proliferation defect observed in the palates of some EphB2 lacz/lacz
À/À embryos may involve one or both of these pathways.
We have shown that that, when placed in contact, Eph-B2 lacZ/lacZ
À/À palatal shelves were able to fuse. Thus, in the secondary mouse palate, EphB2 forward signalling and EphB3 protein are not required for midline fusion. Interestingly, both forward and reverse signalling from EphB/ephrinB proteins appear to be essential for normal adhesion/ fusion events in urogenital development (Dravis et al., 2004) , while EphA7 and ephrinA5 are expressed in cranial neural folds and appear to play a role in cell adhesion during neural tube closure (Holmberg et al., 2000) . It seems that either the function of EphB2 and EphB3 receptors is tissue specific or, perhaps more likely, other Eph receptors are involved in adhesion of these tissues and that different Eph receptors/ephrins play varying roles during development. Although EphB2/ EphB3 forward signalling is not required for palatal adhesion/fusion, it remains possible that other Eph receptors play a role in this process as at least two ephrin Bs are required for palatal adhesion/fusion (Risley et al., manuscript in preparation).
The observation that mice homozygous null for either EphB3 or EphB3 develop normal palates Henkemeyer et al., 1996) demonstrated functional redundancy between these two proteins in palate development. As the palate phenotype observed in EphB2
À/À and EphB2 lacZ/lacZ /EphB3 À/À embryos is of reduced penetrance, it is possible that at least one more Eph receptor also plays a role in palate development. In summary, we have provided compelling evidence that Eph receptor forward signalling is critical for normal murine palate development. Further study with this mouse model will provide insight into the molecular mechanisms of palate development and determine the signalling pathways involved in its regulation by EphB2/B3. It may also be useful for understanding human palate development, particularly as the regions in the human genome in which EphB2 and EphB3 reside have been linked to cleft palate in humans (Martinelli et al., 2001; van Bokhoven et al., 1999) .
4.
Materials and methods
Animals
The generation and genotyping of EphB2 and EphB3 mutant mice has been described previously. The plug date of timed-mated females was designated as E0.5. To harvest embryos, the timed-pregnant female was euthanised by cervical dislocation. Foetuses were delivered after amnioectomy and removal of the placenta and suspended in a bath of ice-cold PBS for 20-30 min prior to fixation or evisceration.
Histological staining
Haemotoxylin and eosin staining was performed on 4% paraformaldehyde (PFA) fixed, paraffin wax embedded 7 lm coronal sections from staged embryonic heads of EphB3 À/À and EphB2 lacZ/lacZ /EphB3 À/À mice.
Immunohistochemistry
Tissue sections were deparaffinised in xylene and rehydrated in graded alcohols. Endogenous peroxidase activity was removed and non-specific secondary antibody binding was blocked in 4% rabbit serum. Primary antibodies (Santa Cruz Biotechnologies) were diluted in PBS and applied for 1 h at room temperature and then washed in PBS. Goat antirabbit secondary antibody (Vector Laboratories Inc.) was applied to each section. After washing in PBS, Vectastain ABC kit (Vector Laboratories Inc.) was applied to each section followed by addition of Diaminobenzidine (DAB, Vector Laboratories Inc.) to visualise the antibody signal. Sections were blued in water then dehydrated in graded alcohols, placed in xylene, mounted and coverslipped.
Cell proliferation and apoptosis assays
Pregnant females were injected intraperitoneally with 1.5 ml/100 g (4.5 mg per 100 g) body weight of 5-bromo-2 0 -deoxyuridine (BrdU) (GE Healthcare UK Ltd.). After 2 h the time-mated female was killed by cervical dislocation. PFA-fixed, wax embedded tissue sections were deparaffinised in xylene and rehydrated in graded alcohols. Endogenous peroxidase activity was removed and non-specific secondary antibody binding was blocked. Sections were incubated in 4 M HCl at 37°C for 10 min and washed in borate buffer. After blocking in 4% rabbit serum for 20 min, sections were incubated at room temperature for 1 h with anti-BrdU antibody (Abcam plc, 1:100). After washing in PBS, sections were incubated for 30 min at room temperature in biotinylated rabbit anti-rat antibody (Vector Laboratories Inc., 1:200). Sections were incubated for 30 min in Vectastain ABC peroxidase and washed as before. To develop the signal, DAB was applied to sections for 10 min. The reaction was stopped by quenching the sections in distilled water. Sections were counterstained in Harris' haematoxylin for 10 s and ''blued'' in running water for 5 min. Sections were dehydrated in graded alcohols then placed in xylene. Sections were mounted and coverslipped. Slides were randomised and images were captured using a Leica microscope. Using morphological features of the palate, a line was drawn on each image to determine the region of the palatal shelf to be analysed. Within this region, the number of BrdU positive cells and total number of cells was counted for each palatal shelf on each section. Five sections from equivalent regions of the palate were analysed per foetus and averaged. Statistical analysis was undertaken using SPSS.
The TUNEL assay was performed using the protocol and reagents from the In Situ Cell Death Detection Kit (Roche Applied Science).
4.5.
Palatal shelf area and cell density analysis
The sections processed for BrdU staining were also used for the palatal shelf area and density analysis. Five sections per foetus were used. These were approximately equally spaced apart with the first close to the most anterior, and the fifth close to the posterior, part of the secondary palate. To ensure comparability between samples, at each of the five positions that sections were taken from, morphological features of the head such as the tooth germ and nasal septum were used when choosing sections. After staining, slides were randomised by another individual to prevent investigator bias during the analysis and images were captured using a Leica microscope. Using the Photoshop TM software package a line was drawn on each image to determine the cross-sectional area of the palatal shelf to be measured (see figure below) , corresponding to the tip of the palatal shelf at each anteroposterior position in the palate. Again, this was equivalent between samples. Both palatal shelves on each section were measured. Next, the palatal shelf tip area was measured using the Image Pro-Plus TM software package. Cell density was analysed by counting the number of cells within this area and dividing this by the area of each shelf. Samples were then un-randomised and an average of the five sections for each foetus was taken for both area and density measurements. The statistical analyses were undertaken using the SPSS software package.
4.6.
Palatal shelf organ culture
To assay palatal fusion, the heads of E13.5, E14.5 and E16.5 foetuses were placed in warm PBS/hanks balanced salt solution (HBSS). The head was dissected from the lower jaw and body and placed in warm Dulbecco's modified eagles medium (DMEM)/F12. The palatal shelves were isolated and placed on a Millipore TM membrane (Millipore (UK) Limited, Watford, UK). Shelves were then cultured for 72 h in DMEM/F12 complete media (DMEM/F12 + 1· L-glutamine + 1· antibiotic, antimycotic solution). After 72 h, cultures were fixed in 4% PFA in PBS for 20 min, placed in 70% ethanol at 4°C overnight then embedded in paraffin wax.
